Janus Henderson Group PLC Immunity Bio, Inc. Transaction History
Janus Henderson Group PLC
- $207 Billion
- Q3 2025
A detailed history of Janus Henderson Group PLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 118,739 shares of IBRX stock, worth $246,977. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118,739
Previous 118,739
-0.0%
Holding current value
$246,977
Previous $313,000
6.71%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IBRX
# of Institutions
299Shares Held
137MCall Options Held
2.59MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA27.7MShares$57.5 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY12.8MShares$26.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$23.8 Million0.0% of portfolio
-
State Street Corp Boston, MA11.3MShares$23.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$14.3 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $833M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...